vs
Side-by-side financial comparison of DUOS TECHNOLOGIES GROUP, INC. (DUOT) and Protalix BioTherapeutics, Inc. (PLX). Click either name above to swap in a different company.
DUOS TECHNOLOGIES GROUP, INC. is the larger business by last-quarter revenue ($9.5M vs $9.1M, roughly 1.0× Protalix BioTherapeutics, Inc.). DUOS TECHNOLOGIES GROUP, INC. runs the higher net margin — -33.8% vs -60.3%, a 26.5% gap on every dollar of revenue. On growth, DUOS TECHNOLOGIES GROUP, INC. posted the faster year-over-year revenue change (547.5% vs -49.9%). Protalix BioTherapeutics, Inc. produced more free cash flow last quarter ($1.6M vs $-18.6M). Over the past eight quarters, DUOS TECHNOLOGIES GROUP, INC.'s revenue compounded faster (149.0% CAGR vs -6.7%).
DUOS Technologies Group Inc. develops and deploys AI-powered automation, inspection, and security solutions for railway transportation, critical infrastructure, and commercial clients across North America. Its offerings include real-time monitoring systems and safety tools that help customers boost efficiency, reduce risks, and strengthen site security.
Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.
DUOT vs PLX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.5M | $9.1M |
| Net Profit | $-3.2M | $-5.5M |
| Gross Margin | 26.7% | 49.4% |
| Operating Margin | -36.1% | -51.1% |
| Net Margin | -33.8% | -60.3% |
| Revenue YoY | 547.5% | -49.9% |
| Net Profit YoY | 6.1% | -184.8% |
| EPS (diluted) | $-0.10 | $-0.06 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.5M | $9.1M | ||
| Q3 25 | $6.9M | $17.9M | ||
| Q2 25 | $5.7M | $15.7M | ||
| Q1 25 | $5.0M | $10.1M | ||
| Q4 24 | $1.5M | $18.2M | ||
| Q3 24 | $3.2M | $18.0M | ||
| Q2 24 | $1.5M | $13.5M | ||
| Q4 23 | $1.5M | $10.5M |
| Q4 25 | $-3.2M | $-5.5M | ||
| Q3 25 | $-1.0M | $2.4M | ||
| Q2 25 | $-3.5M | $164.0K | ||
| Q1 25 | $-2.1M | $-3.6M | ||
| Q4 24 | $-3.4M | $6.5M | ||
| Q3 24 | $-1.4M | $3.2M | ||
| Q2 24 | $-3.2M | $-2.2M | ||
| Q4 23 | $-3.2M | $-6.0M |
| Q4 25 | 26.7% | 49.4% | ||
| Q3 25 | 36.6% | 53.4% | ||
| Q2 25 | 26.5% | 62.5% | ||
| Q1 25 | 26.5% | 19.1% | ||
| Q4 24 | -22.6% | 78.7% | ||
| Q3 24 | 28.4% | 53.4% | ||
| Q2 24 | -14.2% | 29.8% | ||
| Q4 23 | 19.9% | 15.5% |
| Q4 25 | -36.1% | -51.1% | ||
| Q3 25 | -16.2% | 11.9% | ||
| Q2 25 | -60.0% | 7.5% | ||
| Q1 25 | -36.1% | -41.0% | ||
| Q4 24 | -211.2% | 39.6% | ||
| Q3 24 | -59.3% | 22.2% | ||
| Q2 24 | -212.9% | -18.0% | ||
| Q4 23 | -208.4% | -53.5% |
| Q4 25 | -33.8% | -60.3% | ||
| Q3 25 | -15.1% | 13.2% | ||
| Q2 25 | -61.3% | 1.0% | ||
| Q1 25 | -42.0% | -35.8% | ||
| Q4 24 | -233.2% | 35.6% | ||
| Q3 24 | -43.3% | 18.0% | ||
| Q2 24 | -212.1% | -16.4% | ||
| Q4 23 | -207.1% | -57.6% |
| Q4 25 | $-0.10 | $-0.06 | ||
| Q3 25 | $-0.06 | $0.03 | ||
| Q2 25 | $-0.30 | $0.00 | ||
| Q1 25 | $-0.18 | $-0.05 | ||
| Q4 24 | $-0.40 | $0.10 | ||
| Q3 24 | $-0.18 | $0.03 | ||
| Q2 24 | $-0.43 | $-0.03 | ||
| Q4 23 | $-0.43 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $14.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $48.6M | $48.2M |
| Total Assets | $63.4M | $82.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $14.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $17.9M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | $613.6K | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q4 23 | — | $23.6M |
| Q4 25 | $48.6M | $48.2M | ||
| Q3 25 | $49.5M | $52.9M | ||
| Q2 25 | $4.7M | $49.9M | ||
| Q1 25 | $5.2M | $45.2M | ||
| Q4 24 | $2.3M | $43.2M | ||
| Q3 24 | $2.5M | $32.4M | ||
| Q2 24 | $2.9M | $28.6M | ||
| Q4 23 | $5.4M | $33.6M |
| Q4 25 | $63.4M | $82.3M | ||
| Q3 25 | $69.8M | $82.3M | ||
| Q2 25 | $31.1M | $78.5M | ||
| Q1 25 | $34.1M | $73.9M | ||
| Q4 24 | $35.0M | $73.4M | ||
| Q3 24 | $22.0M | $61.6M | ||
| Q2 24 | $21.2M | $91.5M | ||
| Q4 23 | $12.8M | $84.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $2.0M |
| Free Cash FlowOCF − Capex | $-18.6M | $1.6M |
| FCF MarginFCF / Revenue | -196.3% | 17.8% |
| Capex IntensityCapex / Revenue | 167.6% | 4.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-37.4M | $-13.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | $2.0M | ||
| Q3 25 | $-3.2M | $-3.7M | ||
| Q2 25 | $-3.2M | $-5.2M | ||
| Q1 25 | $-4.7M | $-5.1M | ||
| Q4 24 | $2.7M | $4.0M | ||
| Q3 24 | $-2.3M | $4.1M | ||
| Q2 24 | $-1.9M | $-3.6M | ||
| Q4 23 | $-3.1M | $3.6M |
| Q4 25 | $-18.6M | $1.6M | ||
| Q3 25 | $-9.6M | $-4.2M | ||
| Q2 25 | $-4.0M | $-5.7M | ||
| Q1 25 | $-5.2M | $-5.4M | ||
| Q4 24 | $2.4M | $3.6M | ||
| Q3 24 | $-2.9M | $4.0M | ||
| Q2 24 | $-2.8M | $-3.8M | ||
| Q4 23 | $-3.4M | $3.3M |
| Q4 25 | -196.3% | 17.8% | ||
| Q3 25 | -139.7% | -23.7% | ||
| Q2 25 | -69.6% | -36.2% | ||
| Q1 25 | -105.9% | -53.0% | ||
| Q4 24 | 166.2% | 19.6% | ||
| Q3 24 | -90.2% | 22.4% | ||
| Q2 24 | -184.3% | -28.1% | ||
| Q4 23 | -223.2% | 31.9% |
| Q4 25 | 167.6% | 4.4% | ||
| Q3 25 | 93.8% | 2.8% | ||
| Q2 25 | 13.8% | 2.8% | ||
| Q1 25 | 11.6% | 3.0% | ||
| Q4 24 | 19.5% | 2.3% | ||
| Q3 24 | 20.5% | 0.5% | ||
| Q2 24 | 58.0% | 1.3% | ||
| Q4 23 | 19.5% | 2.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DUOT
| Services And Consulting Related Parties | $8.5M | 90% |
| Other | $929.3K | 10% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
